4
Changes in Ownership
Indaptus Therapeutics, Inc. Filed Acc 0001493152-22-035926
Chief Medical Officer bought 1,150 shares at an average $2.19 ($2,520)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Litchev Boyan Vesselinov Chief Medical Officer | 2022-01-31 | Purchase | +100 | $4.65 | $465 | 100 | D |
| Litchev Boyan Vesselinov Chief Medical Officer | 2022-03-02 | Purchase | +50 | $4.09 | $205 | 150 | D |
| Litchev Boyan Vesselinov Chief Medical Officer | 2022-11-22 | Purchase | +500 | $1.83 | $915 | 650 | D |
| Litchev Boyan Vesselinov Chief Medical Officer | 2022-12-01 | Purchase | +500 | $1.87 | $935 | 1,150 | D |
| Open-market purchases · 1,150 sh · avg $2.19 · $2,520 | |||||||
Loading xslF345X03/ownership.xml…